NO20052251L - Nasalt anvendbart farmasoytisk preparat og fremstilling derav. - Google Patents

Nasalt anvendbart farmasoytisk preparat og fremstilling derav.

Info

Publication number
NO20052251L
NO20052251L NO20052251A NO20052251A NO20052251L NO 20052251 L NO20052251 L NO 20052251L NO 20052251 A NO20052251 A NO 20052251A NO 20052251 A NO20052251 A NO 20052251A NO 20052251 L NO20052251 L NO 20052251L
Authority
NO
Norway
Prior art keywords
composition
buffer
pharmaceutical composition
osmotic
preparation
Prior art date
Application number
NO20052251A
Other languages
English (en)
Norwegian (no)
Inventor
Gerhard Hantich
Ernst Hesse
Helmut Scheidl
Wolfgang H Nitschmann
Original Assignee
Gebro Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gebro Pharma Gmbh filed Critical Gebro Pharma Gmbh
Publication of NO20052251L publication Critical patent/NO20052251L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20052251A 2002-10-10 2005-05-09 Nasalt anvendbart farmasoytisk preparat og fremstilling derav. NO20052251L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0154002A AT413078B (de) 2002-10-10 2002-10-10 Verwendung eines puffers auf basis von apfelsäure für die herstellung einer nasal applizierbaren zubereitung
PCT/AT2003/000306 WO2004032896A1 (de) 2002-10-10 2003-10-09 Nasal applizierbare pharmazeutische zubereitung und deren herstellung

Publications (1)

Publication Number Publication Date
NO20052251L true NO20052251L (no) 2005-05-09

Family

ID=32074994

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052251A NO20052251L (no) 2002-10-10 2005-05-09 Nasalt anvendbart farmasoytisk preparat og fremstilling derav.

Country Status (9)

Country Link
US (1) US20060127317A1 (de)
EP (1) EP1549288A1 (de)
JP (1) JP2006503868A (de)
AT (1) AT413078B (de)
AU (1) AU2003266811A1 (de)
CA (1) CA2501760A1 (de)
NO (1) NO20052251L (de)
PL (1) PL375762A1 (de)
WO (1) WO2004032896A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007006122A1 (de) * 2007-02-02 2008-08-07 Krewel Meuselbach Gmbh Cistusextrakte
US20130213393A1 (en) 2009-12-22 2013-08-22 Evoke Pharma, Inc. Nasal formulations of metoclopramide
EP3054980B1 (de) * 2013-10-08 2019-09-04 InnoPharma, Inc. Flüssige orale aprepitant-formulierungen
US11517545B2 (en) 2016-12-15 2022-12-06 Evoke Pharma, Inc. Treatment of moderate and severe gastroparesis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5514670A (en) * 1993-08-13 1996-05-07 Pharmos Corporation Submicron emulsions for delivery of peptides
AT409081B (de) * 2000-02-16 2002-05-27 Gebro Pharma Gmbh Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung

Also Published As

Publication number Publication date
AT413078B (de) 2005-11-15
EP1549288A1 (de) 2005-07-06
AU2003266811A1 (en) 2004-05-04
PL375762A1 (en) 2005-12-12
WO2004032896A1 (de) 2004-04-22
US20060127317A1 (en) 2006-06-15
CA2501760A1 (en) 2004-04-22
JP2006503868A (ja) 2006-02-02
ATA15402002A (de) 2005-04-15

Similar Documents

Publication Publication Date Title
BR0311877A (pt) Preparações ácidas de insulina com estabilidade aperfeiçoada
CA2342856A1 (en) Stabilized two-part disinfecting system and compositions and methods related thereto
CA2102693A1 (en) Protein formulation comprising growth hormone
ATE535943T1 (de) Dotierpasten zur erzeugung von p, p+ und n, n+ bereichen in halbleitern
WO2004032979A3 (en) Acidified chlorite compositions containing nitrogenous stabilizers and systems and methods related thereto
NO20012661L (no) Fremgangsmåte for å redusere astringens av tinn(II) i dentifriciumsammensetninger
DE60318867D1 (de) Lösung zur nagel-verwendung
IS8870A (is) Lyfjablanda sem felur í sér andrógen
WO2005116081A3 (en) Stable protein storage and stable nucleic acid storage in recoverable form
CA2027483A1 (fr) Procede de preparation d'une solution aqueuse effervescente ayant une action emolliente sur la cuticule des ongles, composition pour la mise en oeuvre dudit procede et traitement cosmetique correspondant
EP1236398A4 (de) Mikrobizide zusammensetzungen
CA2391076A1 (en) Solutions containing epinastin
EP1153901A3 (de) Zusammensetzung zur Erhöhung der Nahrungsqualität von Gemüse und deren Verwendung
CA2256410A1 (en) Stable pharmaceutical composition of bdnf
DE602004015725D1 (de) Stabilisierte lyophilisierte zubereitungen mit gewebefaktor-inhibitor (tfpi) oder varianten des gewebefaktor-inhibitors
PL357132A1 (en) Stable, nasally, orally or sublingually applicable pharmaceutical preparation
CA2388056A1 (en) Method of stabilizing dye solutions and stabilized dye compositions
WO2002003974A3 (en) Composition comprising folic acid and zinc for improving male fertility
EP0985347A4 (de) Brausezubereitung für pflanzen
KR930000096A (ko) 제제
MY136546A (en) A pharmaceutical component based on human parathyroid harmone and a pharmaceutical composition for intranasal administration comprising the component
CA2438622A1 (en) Compositions containing creatine and creatinine
WO1999013819A3 (en) Composition and method for reducing stinging in skin
KR950010880A (ko) 안정한 복합비타민 내복액제
WO2004075834A3 (en) Stabilized pharmaceutical compositions of safingol and methods of using the same

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application